Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 17  •  04:00PM ET
2.86
Dollar change
+0.04
Percentage change
1.42
%
IndexRUT P/E- EPS (ttm)-0.90 Insider Own9.75% Shs Outstand149.75M Perf Week-13.86%
Market Cap430.06M Forward P/E- EPS next Y-0.65 Insider Trans1.07% Shs Float135.71M Perf Month-36.87%
Enterprise Value267.46M PEG- EPS next Q-0.18 Inst Own65.45% Short Float22.40% Perf Quarter9.16%
Income-114.60M P/S153.05 EPS this Y10.37% Inst Trans6.83% Short Ratio5.73 Perf Half Y3.25%
Sales2.81M P/B2.04 EPS next Y23.11% ROA-47.73% Short Interest30.39M Perf YTD9.16%
Book/sh1.40 P/C2.55 EPS next 5Y6.53% ROE-55.68% 52W High6.33 -54.82% Perf Year-8.92%
Cash/sh1.12 P/FCF- EPS past 3/5Y5.67% -29.30% ROIC-53.68% 52W Low2.01 42.29% Perf 3Y-6.54%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-1.76% 17.09% Gross Margin-331.55% Volatility11.14% 7.93% Perf 5Y-
Dividend TTM- EV/Sales95.18 EPS Y/Y TTM3.38% Oper. Margin-4229.13% ATR (14)0.34 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.89 Sales Y/Y TTM-33.09% Profit Margin-4071.19% RSI (14)35.72 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.89 EPS Q/Q17.21% SMA20-25.09% Beta2.19 Target Price7.97
Payout- Debt/Eq0.03 Sales Q/Q-77.78% SMA50-18.33% Rel Volume0.97 Prev Close2.82
Employees157 LT Debt/Eq0.02 EarningsNov 12 AMC SMA200-10.23% Avg Volume5.31M Price2.86
IPOJul 22, 2021 Option/ShortYes / Yes EPS/Sales Surpr.2.44% -76.07% Trades Volume5,124,520 Change1.42%
Date Action Analyst Rating Change Price Target Change
Oct-02-25Initiated JP Morgan Overweight
Jul-03-25Resumed Morgan Stanley Overweight $7
Jan-22-25Initiated Needham Buy $9
Oct-02-24Initiated Guggenheim Buy $10
Jul-03-24Initiated Morgan Stanley Overweight $7
Mar-14-24Initiated Scotiabank Sector Outperform $13
Dec-05-23Initiated KeyBanc Capital Markets Overweight $3
May-04-23Initiated H.C. Wainwright Buy $4
Aug-12-22Downgrade JP Morgan Overweight → Underweight
Jul-18-22Initiated Truist Buy $8
Nov-13-25 12:02AM
Nov-12-25 05:25PM
04:05PM
Nov-11-25 07:28AM
Nov-10-25 08:15AM
09:15AM Loading…
Nov-06-25 09:15AM
Oct-29-25 04:05PM
Oct-27-25 08:00AM
Oct-15-25 08:00AM
Oct-13-25 12:12PM
Sep-21-25 09:26AM
Sep-11-25 08:00AM
Aug-25-25 04:05PM
Aug-20-25 08:00AM
Aug-13-25 03:12AM
05:20PM Loading…
Aug-12-25 05:20PM
04:05PM
Aug-11-25 09:31AM
Aug-07-25 10:00AM
02:00AM
Aug-06-25 10:00AM
Aug-05-25 05:15PM
Aug-04-25 05:15PM
Jul-30-25 04:05PM
Jul-25-25 09:56AM
Jul-24-25 08:45PM
04:54PM
Jul-11-25 07:15PM
Jul-07-25 08:30AM
08:00AM
08:00AM Loading…
May-20-25 08:00AM
May-14-25 08:32AM
03:17AM
May-13-25 05:30PM
04:05PM
04:01PM
May-12-25 09:35AM
Apr-14-25 04:05PM
11:40AM
Apr-03-25 03:15PM
Mar-31-25 07:15AM
Mar-26-25 08:00AM
Mar-21-25 10:57PM
Mar-19-25 09:08AM
03:03AM
Mar-18-25 04:05PM
Mar-04-25 04:05PM
04:00PM
08:00AM
Mar-01-25 05:19PM
Feb-18-25 08:00AM
Feb-12-25 09:24AM
Feb-11-25 09:00AM
Jan-24-25 11:54AM
Jan-22-25 01:22PM
08:00AM
Jan-17-25 05:58PM
01:54PM
Jan-11-25 07:40AM
Jan-10-25 05:48PM
07:30AM
Jan-08-25 01:14PM
09:12AM
07:00AM
06:32AM
Jan-06-25 08:00AM
Jan-02-25 08:00AM
Dec-30-24 02:39PM
Dec-13-24 08:10AM
Dec-12-24 08:00AM
08:00AM
Nov-21-24 08:00AM
Nov-20-24 09:15AM
Nov-13-24 02:07AM
Nov-12-24 09:23PM
08:50AM
07:30AM
Nov-11-24 07:15AM
Nov-07-24 08:00AM
Oct-31-24 08:00AM
Oct-24-24 08:00AM
Oct-15-24 08:00AM
Aug-31-24 02:37PM
Aug-30-24 10:30AM
Aug-21-24 08:00AM
Aug-14-24 05:30PM
04:01PM
Aug-12-24 08:00AM
Jul-31-24 04:25AM
Jul-10-24 08:00AM
Jul-03-24 04:00PM
Jun-21-24 11:08AM
Jun-12-24 08:00AM
May-28-24 08:00AM
May-20-24 09:32PM
May-16-24 07:15AM
May-15-24 03:01AM
May-14-24 11:53AM
07:30AM
May-12-24 03:26PM
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pangalos Menelas NDirectorSep 22 '25Buy2.6695,785254,788113,960Sep 24 04:03 PM
Bedrick ToddSVP, CAOSep 22 '25Buy2.7010,00027,000180,428Sep 24 04:03 PM
Busch AndreasChief Innovation OfficerJul 28 '25Buy3.0450,000152,000327,264Jul 29 08:37 AM